Business Context and Reporting Period
Company: Coca-Cola Europacific Partners Plc (CCEP)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: September 24, 2025, through September 30, 2025
Business Overview: CCEP is a leading consumer goods company operating in 31 countries, serving nearly 600 million consumers and over 4 million customers. The company is listed on Euronext Amsterdam, NASDAQ, the London Stock Exchange, and Spanish Stock Exchanges.
Key Financial Metrics and Share Repurchase Activity
This filing details specific share repurchase transactions and program updates rather than operational financial results (revenue, profit, or cash flow). The filing text does not provide a clear value for revenue, profit, margins, debt, or liquidity for the period.
| Date of Purchase | Venue | Shares Purchased | Average Price (USD/GBP) | Agent |
|---|---|---|---|---|
| Sept 23, 2025 | US Trading Venues | 39,046 | USD 88.8578 | Goldman Sachs |
| Sept 24, 2025 | US Trading Venues | 38,624 | USD 89.8295 | Goldman Sachs |
| Sept 25, 2025 | US Trading Venues | 40,845 | USD 89.5963 | Goldman Sachs |
| Sept 26, 2025 | US Trading Venues | 40,189 | USD 89.2170 | Goldman Sachs |
| Sept 29, 2025 | US Trading Venues | 74,090 | USD 89.3903 | Jefferies LLC |
| Sept 29, 2025 | London Trading Venues | 31,562 | GBP 66.57 (approx) | Jefferies Int. Ltd. |
Material Changes and Program Updates
- Completion of Third Tranche: On September 29, 2025, the Company announced the conclusion of the third tranche of its share buyback program ahead of schedule. This tranche acquired 1,794,369 ordinary shares for a total consideration of approximately EUR 137,921,006.04.
- Change of Agent: The Company has entered into a new arrangement with Jefferies LLC and Jefferies International Limited to execute the next tranche of the program, replacing Goldman Sachs.
- Fourth Tranche Authorization: A new tranche is expected to cover the period from September 29, 2025, to December 19, 2025. The maximum aggregate amount for this tranche is EUR 382,000,000, with up to EUR 102,000,000 allocated for London Trading Venues.
- Share Cancellation: All repurchased shares are being cancelled to reduce issued share capital.
Guidance, Outlook, and Risks
Outlook: The Company expects to repurchase up to EUR 1 billion of ordinary shares in aggregate under the overall program announced on February 14, 2025.
Risks and Contingencies: The filing includes a cautionary note regarding forward-looking statements. Actual results may differ materially due to risks outlined in the "Risk Factors" section of the 2024 Annual Report on Form 20-F. No specific new operational risks or contingencies were detailed in this filing beyond standard market and regulatory compliance references.
Key Facts for Investor Verification
- Program Status: Verify the total cumulative amount repurchased to date against the EUR 1 billion aggregate target.
- Agent Transition: Confirm the operational details of the transition from Goldman Sachs to Jefferies for the new tranche.
- Share Count: Monitor the reduction in issued share capital resulting from the cancellation of the 1.79 million shares in the third tranche and subsequent purchases.
- Market Prices: Note the trading range during the reporting period (USD ~88.05–90.24 on US venues; GBP ~65.70–67.10 on London venues).
- Regulatory Compliance: Ensure all transactions comply with the Market Abuse Regulation (EU) No 596/2014 and UK Listing Rules as referenced in the filing.